Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) ...
7don MSN
Reprogramming the epigenetic code affects growth and survival of tumor cells in multiple myeloma
In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of ...
1don MSN
Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...
Learning about early symptoms may help you in the long run. Here are the early symptoms to know, according to medical ...
MMRF continues to drive the critical global research collaborations that lead to scientific breakthroughs and improved patient outcomesNORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the ...
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy.
Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...
News-Medical.Net on MSN
Blocking iron regulating enzyme triggers cancer cell death in multiple myeloma
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback